172 related articles for article (PubMed ID: 15170665)
1. Pretreatment evaluation of combined HIF-1alpha, p53 and p21 expression is a useful and sensitive indicator of response to radiation and chemotherapy in esophageal cancer.
Sohda M; Ishikawa H; Masuda N; Kato H; Miyazaki T; Nakajima M; Fukuchi M; Manda R; Fukai Y; Sakurai H; Kuwano H
Int J Cancer; 2004 Jul; 110(6):838-44. PubMed ID: 15170665
[TBL] [Abstract][Full Text] [Related]
2. Expression of p53 protein in esophageal squamous cell carcinoma: relation to hypoxia-inducible factor-1alpha, angiogenesis and apoptosis.
Kimura S; Kitadai Y; Kuwai T; Tanaka S; Hihara J; Yoshida K; Toge T; Chayama K
Pathobiology; 2005; 72(4):179-85. PubMed ID: 16127293
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of HIF-1alpha expression in patients with esophageal cancer treated with concurrent chemoradiotherapy.
Ogawa K; Chiba I; Morioka T; Shimoji H; Tamaki W; Takamatsu R; Nishimaki T; Yoshimi N; Murayama S
Anticancer Res; 2011 Jun; 31(6):2351-9. PubMed ID: 21737664
[TBL] [Abstract][Full Text] [Related]
4. Expression of hypoxia-inducible factor-1alpha and cell cycle proteins in invasive breast cancer are estrogen receptor related.
Bos R; van Diest PJ; van der Groep P; Shvarts A; Greijer AE; van der Wall E
Breast Cancer Res; 2004; 6(4):R450-9. PubMed ID: 15217513
[TBL] [Abstract][Full Text] [Related]
5. Expression of hypoxic-inducible factor 1alpha predicts metastasis-free survival after radiation therapy alone in stage IIIB cervical squamous cell carcinoma.
Ishikawa H; Sakurai H; Hasegawa M; Mitsuhashi N; Takahashi M; Masuda N; Nakajima M; Kitamoto Y; Saitoh J; Nakano T
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):513-21. PubMed ID: 15380586
[TBL] [Abstract][Full Text] [Related]
6. Expression of hypoxia-inducible factor 1alpha in epithelial ovarian tumors: its impact on prognosis and on response to chemotherapy.
Birner P; Schindl M; Obermair A; Breitenecker G; Oberhuber G
Clin Cancer Res; 2001 Jun; 7(6):1661-8. PubMed ID: 11410504
[TBL] [Abstract][Full Text] [Related]
7. [Relationship between the expression of hypoxia-inducible factor-1alpha and chemotherapy response in esophageal squamous cell carcinoma].
Wu XA; Sun Y; Fan QX; Wang LX; Wang RL
Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(25):1783-5. PubMed ID: 17919389
[TBL] [Abstract][Full Text] [Related]
8. Hyperinducibility of hypoxia-responsive genes without p53/p21-dependent checkpoint in aggressive prostate cancer.
Salnikow K; Costa M; Figg WD; Blagosklonny MV
Cancer Res; 2000 Oct; 60(20):5630-4. PubMed ID: 11059752
[TBL] [Abstract][Full Text] [Related]
9. [Impact of RNA interference targeting hypoxia-inducible factor-1alpha on chemosensitivity in esophageal squamous cell carcinoma cells under hypoxia].
Wu XA; Sun Y; Fan QX; Wang LX; Wang RL; Zhang L
Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(37):2640-4. PubMed ID: 18162154
[TBL] [Abstract][Full Text] [Related]
10. Predictive value of p53 and 14-3-3sigma for the effect of chemoradiation therapy on esophageal squamous cell carcinoma.
Okumura H; Natsugoe S; Matsumoto M; Yokomakura N; Uchikado Y; Takatori H; Ishigami S; Takao S; Aikou T
J Surg Oncol; 2005 Jul; 91(1):84-9. PubMed ID: 15999354
[TBL] [Abstract][Full Text] [Related]
11. Dysregulation of hypoxia inducible factor-1alpha in head and neck squamous cell carcinoma cell lines correlates with invasive potential.
Cohen NA; Lai SY; Ziober AF; Ziober BL
Laryngoscope; 2004 Mar; 114(3):418-23. PubMed ID: 15091212
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of hypoxia-inducible factor 1alpha overexpression as a predictor of tumour recurrence and progression in superficial urothelial bladder carcinoma.
Theodoropoulos VE; Lazaris AC; Kastriotis I; Spiliadi C; Theodoropoulos GE; Tsoukala V; Patsouris E; Sofras F
BJU Int; 2005 Feb; 95(3):425-31. PubMed ID: 15679808
[TBL] [Abstract][Full Text] [Related]
13. Correlation of hypoxia inducible factor-1alpha with lymphatic metastasis via vascular endothelial growth factor-C in human esophageal cancer.
Katsuta M; Miyashita M; Makino H; Nomura T; Shinji S; Yamashita K; Tajiri T; Kudo M; Ishiwata T; Naito Z
Exp Mol Pathol; 2005 Apr; 78(2):123-30. PubMed ID: 15713437
[TBL] [Abstract][Full Text] [Related]
14. Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis.
Carmeliet P; Dor Y; Herbert JM; Fukumura D; Brusselmans K; Dewerchin M; Neeman M; Bono F; Abramovitch R; Maxwell P; Koch CJ; Ratcliffe P; Moons L; Jain RK; Collen D; Keshert E
Nature; 1998 Jul; 394(6692):485-90. PubMed ID: 9697772
[TBL] [Abstract][Full Text] [Related]
15. The relation between hypoxia-inducible factor (HIF)-1alpha expression with p53 expression and outcome in surgically treated supraglottic laryngeal cancer.
Cabanillas R; Rodrigo JP; Secades P; Astudillo A; Nieto CS; Chiara MD
J Surg Oncol; 2009 May; 99(6):373-8. PubMed ID: 19226532
[TBL] [Abstract][Full Text] [Related]
16. Expression of the prolyl isomerase Pin1 is a useful indicator of sensitivity to chemoradiotherapy in advanced esophageal squamous cell carcinoma.
Fukuchi M; Fukai Y; Sohda M; Miyazaki T; Nakajima M; Inose T; Tanaka N; Tsukada K; Kato H; Kuwano H
Oncol Rep; 2009 Apr; 21(4):853-9. PubMed ID: 19287979
[TBL] [Abstract][Full Text] [Related]
17. Levels of hypoxia-inducible factor-1alpha independently predict prognosis in patients with lymph node negative breast carcinoma.
Bos R; van der Groep P; Greijer AE; Shvarts A; Meijer S; Pinedo HM; Semenza GL; van Diest PJ; van der Wall E
Cancer; 2003 Mar; 97(6):1573-81. PubMed ID: 12627523
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of hypoxia-inducible factor 1α, and its correlation with p53 and vascular endothelial growth factor expression in resectable esophageal squamous cell carcinoma.
Shao N; Han Y; Song L; Song W
J Cancer Res Ther; 2020; 16(2):269-275. PubMed ID: 32474512
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of hypoxia-inducible factor HIF-1alpha predicts early relapse in breast cancer: retrospective study in a series of 745 patients.
Dales JP; Garcia S; Meunier-Carpentier S; Andrac-Meyer L; Haddad O; Lavaut MN; Allasia C; Bonnier P; Charpin C
Int J Cancer; 2005 Sep; 116(5):734-9. PubMed ID: 15849727
[TBL] [Abstract][Full Text] [Related]
20. [Expression of hypoxia-inducible factor-1alpha and vessel endothelial growth factor in esophageal squamous cell carcinoma and clinico-pathological significance thereof].
Yu ZT; Zhao HF; Shang XB
Zhonghua Yi Xue Za Zhi; 2008 Sep; 88(35):2465-9. PubMed ID: 19080625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
